{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T03:40:10Z","timestamp":1685936410749},"reference-count":75,"publisher":"Cambridge University Press (CUP)","issue":"1","license":[{"start":{"date-parts":[[2011,2,3]],"date-time":"2011-02-03T00:00:00Z","timestamp":1296691200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sci Context"],"published-print":{"date-parts":[[2011,3]]},"abstract":"<jats:title>Argument<\/jats:title><jats:p>A number of issues related to vaccines and vaccinations in society are discussed in this paper. Our purpose is to merge an analysis of some recent changes in the vaccine market with social science research on the relationship between citizens and authorities. The article has two empirical parts. The first shows how the vaccine market, which for many years has had immense financial problems, nowadays seems to becoming economically vitalized, mostly due to the production of new and profitable vaccines. However prosperous the future may appear, certain reactions from the public regarding vaccination initiatives offer insight into inherent problems of vaccine policies in many Western countries. In the second part of the article, these problems are exemplified with the recent controversy over the MMR (measles, mumps, and rubella) vaccine. We conclude that in spite of the improving profit-margins, the vaccine market remains vulnerable and insecure. Vaccines are permeated by<jats:italic>society<\/jats:italic>, even more so than pharmaceutics that are used to cure or alleviate illnesses. Radical changes in financial conditions with promises of a more profitable market will not, we argue, solve other even more fundamental problems.<\/jats:p>","DOI":"10.1017\/s0269889710000281","type":"journal-article","created":{"date-parts":[[2011,2,3]],"date-time":"2011-02-03T11:35:13Z","timestamp":1296732913000},"page":"107-125","source":"Crossref","is-referenced-by-count":5,"title":["Dilemmas of a Vitalizing Vaccine Market: Lessons from the MMR Vaccine\/Autism Debate"],"prefix":"10.1017","volume":"24","author":[{"given":"Fredrik","family":"Bragesj\u00f6","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margareta","family":"Hallberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2011,2,3]]},"reference":[{"key":"S0269889710000281_ref75","doi-asserted-by":"crossref","DOI":"10.4135\/9781446222218","volume-title":"Making Sense of Science: Understanding the Social Study of Science","author":"Yearley","year":"2005"},{"key":"S0269889710000281_ref74","unstructured":"World Health Organization (WHO). 2007. \u201cBenefits of immunization.\u201d URL http:\/\/www.who.int\/immunization_delivery\/benefits_of_immunization\/en\/index.html (last accessed June 2007)."},{"key":"S0269889710000281_ref73","unstructured":"World Health Organization (WHO). 2005. \u201cThe history of vaccination.\u201d URL http:\/\/www.who.int\/vaccines-diseases\/history\/history.shtml (last accessed December 2007)."},{"key":"S0269889710000281_ref72","doi-asserted-by":"publisher","DOI":"10.1093\/eurpub\/cki194"},{"key":"S0269889710000281_ref71","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)11096-0"},{"key":"S0269889710000281_ref69","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)01239-8"},{"key":"S0269889710000281_ref67","unstructured":"Swedish Institute for Infectious Disease Control. 2007. SMI-dag om barnvaccinationsprogrammet (Information on Child Vaccination Programs). Solna, Sweden, 2007-11-21. URL http:\/\/www.smittskyddsinstitutet.se\/om-smi\/utbildningar\/smi-dagar\/tidigare-smi-dagar\/vaccinationer-i-barn-och-skolhalsovarden\/ (last accessed November 2009)."},{"key":"S0269889710000281_ref65","volume-title":". Immunization safety review: thimerosal-containing vaccines and neurodevelopmental disorders.","author":"Stratton","year":"2001"},{"key":"S0269889710000281_ref59","doi-asserted-by":"publisher","DOI":"10.1126\/science.1075173"},{"key":"S0269889710000281_ref56","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.322.7278.82"},{"key":"S0269889710000281_ref50","first-page":"3658","article-title":"Vaccination mot m\u00e4ssling, p\u00e5ssjuka och r\u00f6da hund har god skyddseffekt. Att avst\u00e5 fr\u00e5n att vaccinera skulle allvarligt hota v\u00e5rt goda immunitetsl\u00e4ge\u201d (MMR vaccination gives good protection)","volume":"98","author":"Linde","year":"2001","journal-title":"L\u00e4kartidningen"},{"key":"S0269889710000281_ref48","volume-title":"Making Markets for Vaccines: Ideas to Action. The Report of the Center for the Global Development Advance Market Commitment Working Group.","author":"Levine","year":"2005"},{"key":"S0269889710000281_ref46","volume-title":"Vaccine Anxieties. Global Science, Child Health and Society.","author":"Leach","year":"2007"},{"key":"S0269889710000281_ref45","volume-title":"MMR mobilisation: citizens and science in a British vaccine controversy.","author":"Leach","year":"2005"},{"key":"S0269889710000281_ref64","volume-title":"Vaccines for the 21st century: a tool for decisionmaking","author":"Stratton","year":"2000"},{"key":"S0269889710000281_ref39","volume-title":"Financing Vaccines in the 21st Century: Assuring Access and Availability","year":"2004"},{"key":"S0269889710000281_ref34","doi-asserted-by":"publisher","DOI":"10.1017\/S0269889708001695"},{"key":"S0269889710000281_ref32","volume-title":"Konflikt eller konsensus? Om kontroversstudier som forskningsf\u00e4lt","author":"Hallberg","year":"2003"},{"key":"S0269889710000281_ref31","doi-asserted-by":"publisher","DOI":"10.1017\/S026988970800166X"},{"key":"S0269889710000281_ref30","volume-title":"The Search for New Vaccines: The Effects of the Vaccines for Children Program","author":"Grabowski","year":"1997"},{"key":"S0269889710000281_ref29","volume-title":"Modernity and Self-identity. Self and Society in the Late Modern Age.","author":"Giddens","year":"1991"},{"key":"S0269889710000281_ref27","volume-title":"Networks of Innovation: Vaccine Development at Merck, Sharp and Dohme, and Mulford, 1895-1995","author":"Galambos","year":"1995"},{"key":"S0269889710000281_ref26","doi-asserted-by":"publisher","DOI":"10.1542\/peds.108.4.e58"},{"key":"S0269889710000281_ref25","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7424.1124-b"},{"key":"S0269889710000281_ref23","doi-asserted-by":"crossref","DOI":"10.1215\/9780822386506","volume-title":"Bodily Matters: The Anti-Vaccination Movement in England, 1853-1907","author":"Durbach","year":"2005"},{"key":"S0269889710000281_ref22","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-6296(02)00126-1"},{"key":"S0269889710000281_ref20","doi-asserted-by":"publisher","DOI":"10.7208\/chicago\/9780226113692.001.0001"},{"key":"S0269889710000281_ref19","volume-title":"State of Immunity: The Politics of Vaccination in Twentieth-Century America","author":"Colgrove","year":"2006"},{"key":"S0269889710000281_ref18","unstructured":"Centers for Disease Control and Prevention. 2008. \u201cCDC Vaccine Price List.\u201d URL: http:\/\/www.cdc.gov\/vaccines\/programs\/vfc\/cdc-vac-price-list.htm (last accessed November 2009)."},{"key":"S0269889710000281_ref17","unstructured":"Centers for Disease Control and Prevention. 2007. \u201cRecommended Immunization Schedule for Persons Aged 0\u20136 Years, United States 2007.\u201d URL http:\/\/www.cdc.gov\/vaccines\/recs\/schedules\/downloads\/child\/2007\/child-schedule-color-print.pdf (last accessed July 2009)."},{"key":"S0269889710000281_ref16","unstructured":"Centers for Disease Control and Prevention. 1995. \u201cCDC Vaccine Price List.\u201d URL http:\/\/www.cdc.gov\/vaccines\/programs\/vfc\/downloads\/archived-vfc-price-list-files\/1995-vac-pricelist-archive.pdf (last accessed November 2009)."},{"key":"S0269889710000281_ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.02.033"},{"key":"S0269889710000281_ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2005.05.033"},{"key":"S0269889710000281_ref15","doi-asserted-by":"publisher","DOI":"10.1017\/S0269889708001713"},{"key":"S0269889710000281_ref9","doi-asserted-by":"publisher","DOI":"10.1177\/0038038505050536"},{"key":"S0269889710000281_ref7","first-page":"228","article-title":"Vetenskaplig kunskap som problem f\u00f6r beslutsfattare och praktiker? Exemplet m\u00e4sslingsvaccination","volume":"13","author":"Bragesj\u00f6","year":"2006","journal-title":"Socialvetenskaplig tidskrift"},{"key":"S0269889710000281_ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.respol.2004.12.001"},{"key":"S0269889710000281_ref4","volume-title":"Risk Society: Towards a New Modernity","author":"Beck","year":"1992"},{"key":"S0269889710000281_ref3","doi-asserted-by":"publisher","DOI":"10.1016\/B978-012107258-2\/50027-5"},{"key":"S0269889710000281_ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.respol.2004.10.003"},{"key":"S0269889710000281_ref70","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)16017-0"},{"key":"S0269889710000281_ref1","doi-asserted-by":"publisher","DOI":"10.1002\/1096-9071(200011)62:3<377::AID-JMV10>3.0.CO;2-1"},{"key":"S0269889710000281_ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2004.04.018"},{"key":"S0269889710000281_ref38","volume-title":"MMR, Science and Fiction: Exploring the Vaccine Crisis","author":"Horton","year":"2004"},{"key":"S0269889710000281_ref28","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(97)04334-1"},{"key":"S0269889710000281_ref58","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2004.12.014"},{"key":"S0269889710000281_ref66","unstructured":"Swedish Institute for Infectious Disease Control. 2005. Epidemiologisk \u00e5rsrapport 2004 [The Annual Epidemiolocial Report 2004 of The Swedish Institute for Infectious Disease Control]. Stockholm: Swedish Institute for Infectious Disease Control."},{"key":"S0269889710000281_ref37","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)15699-7"},{"key":"S0269889710000281_ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2007.04.023"},{"key":"S0269889710000281_ref63","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2007.02.071"},{"key":"S0269889710000281_ref41","volume-title":"Evidence of Harm: Mercury in Vaccines and the Autism Epidemic: a Medical Controversy","author":"Kirby","year":"2005"},{"key":"S0269889710000281_ref55","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(03)00532-2"},{"key":"S0269889710000281_ref53","volume-title":"Economics of vaccine development and implementation: changes over the past 20 years","author":"Milstien","year":"2002"},{"key":"S0269889710000281_ref8","volume-title":"I forskningens n\u00e4rhet: en studie av MPR-kontroversens bakgrund och f\u00f6rvecklingar","author":"Bragesj\u00f6","year":"2009"},{"key":"S0269889710000281_ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-9020.2007.00007.x"},{"key":"S0269889710000281_ref42","doi-asserted-by":"publisher","DOI":"10.3386\/w7716"},{"key":"S0269889710000281_ref43","doi-asserted-by":"crossref","DOI":"10.3386\/w7717","volume-title":"Creating Markets for New Vaccines. Part II: Design Issues.","author":"Kremer","year":"2000"},{"key":"S0269889710000281_ref68","unstructured":"Swedish Institute for Infectious Disease Control. 2008. Vaccinationsstatistik fr\u00e5n barnav\u00e5rdscentralerna, insamlad januari 2008, g\u00e4llande barn f\u00f6dda 2005 (Vaccination statistics from Swedish child healthcare centers, collected in January 2008, for children born in 2005). URL http:\/\/www.smittskyddsinstitutet.se\/upload\/5216\/vaccrapport-08-bvc-sverige.pdf (last accessed September 2009)."},{"key":"S0269889710000281_ref36","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-9566.2007.00544.x"},{"key":"S0269889710000281_ref33","unstructured":"Hellbom Ola . 2007. \u201cHet vaccinmarknad lockar j\u00e4ttarna\u201d (Pharmaceutical Giants drawn to heated Vaccine Market). Dagens Industri (May 3):28\u201329."},{"key":"S0269889710000281_ref52","unstructured":"Mercer Management Consulting. 2002. Lessons Learned: New Procurement Strategies for Vaccines. Final report to the GAVI Board, June. URL: http:\/\/www.gaviftf.info\/docs_activities\/pdf\/lessons_learned_draft_final.pdf (last accessed June 2006)."},{"key":"S0269889710000281_ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2005.07.063"},{"key":"S0269889710000281_ref40","unstructured":"Kalla fakta (Cold Facts) on TV4. 2000. \u201cDen enda sanningen\u201d (The only truth). Swedish TV program by Joachim Dyfvenmark, and Sven Bergman, October 26, 2000."},{"key":"S0269889710000281_ref49","unstructured":"Lindberg Anders . 2007. \u201cNya vaccinationsprogrammet\u201d (The New Vaccination Program). Presentation at SMI-dag om barnvaccinationsprogrammet (Information on the vaccination program). Solna, Sweden, 2007-11-21."},{"key":"S0269889710000281_ref44","volume-title":"Strong Medicine: Creating Incentives for Pharmaceutical Research on Neglected Diseases","author":"Michael","year":"2004"},{"key":"S0269889710000281_ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.05.010"},{"key":"S0269889710000281_ref24","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.epirev.a036121"},{"key":"S0269889710000281_ref60","unstructured":"Reportrarna [The Reporters] on SvT. 1999. \u201cVaccination f\u00f6r vem?\u201d (Vaccination for whom?). Television program by Erik Tjernstr\u00f6m, and Hasse Karlsson, 1999-09-07."},{"key":"S0269889710000281_ref54","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(04)15715-2"},{"key":"S0269889710000281_ref6","doi-asserted-by":"publisher","DOI":"10.1017\/S0269889708001725"},{"key":"S0269889710000281_ref51","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021134"},{"key":"S0269889710000281_ref61","doi-asserted-by":"crossref","DOI":"10.7208\/chicago\/9780226148847.001.0001","volume-title":"A Social History of Truth: Gentility, Credibility, and Scientific Knowledge in Seventeenth-Century England","author":"Shapin","year":"1994"},{"key":"S0269889710000281_ref62","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2006.02.037"},{"key":"S0269889710000281_ref57","doi-asserted-by":"publisher","DOI":"10.1080\/13698570410001678284"},{"key":"S0269889710000281_ref35","doi-asserted-by":"publisher","DOI":"10.1080\/13698570310001606978"}],"container-title":["Science in Context"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0269889710000281","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T02:58:55Z","timestamp":1685933935000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0269889710000281\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,3]]},"references-count":75,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["S0269889710000281"],"URL":"https:\/\/doi.org\/10.1017\/s0269889710000281","relation":{},"ISSN":["0269-8897","1474-0664"],"issn-type":[{"value":"0269-8897","type":"print"},{"value":"1474-0664","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,3]]}}}